Showing 1131-1140 of 1648 results for "".
- Merz Aesthetics Names New US Sales and Marketing Leadershttps://modernaesthetics.com/news/merz-aesthetics-names-new-us-sales-and-marketing-leaders/2475952/Merz Aesthetics has appointed Chris Van Dyk as Vice President of US Sales and DJ Sethares as Vice President of US Marketing, the company announced. Both executives will lead commercial functions across the US to support growth of the company’s aesthetics portfolio. Van Dyk previously serve
- Alma Launches AI-Assisted Skincare System with Nearly 12M Formulation Optionshttps://modernaesthetics.com/news/alma-launches-ai-assisted-skincare-system-with-nearly-12m-formulation-options/2475858/Alma has launched Universkin by Alma, a new AI-assisted medical-grade skincare platform designed to support physicians in offering personalized treatment regimens. The system enables rapid clinical assessment and tailored formulation of topical therapies using an intelligent diagnostic algorithm
- Obagi Medical Acquires Novaestiq to Introduce HA Injectables in US Markethttps://modernaesthetics.com/news/obagi-medical-acquires-novaestiq-to-introduce-ha-injectables-in-us-market/2475814/Obagi Medical is set to expand into aesthetic injectables following the acquisition of Novaestiq Corp., the company behind the Saypha® ChIQ™ and Saypha® MagIQ™ hyaluronic acid (HA) filler products. The transaction was completed by Obagi’s parent company, Waldencast
- Global Botulinum Toxins Market Projected to Reach $15.7 Billion by 2030https://modernaesthetics.com/news/global-botulinum-toxins-market-projected-to-reach-157-billion-by-2030/2475785/The global market for botulinum toxin products is expected to grow from $8.9 billion in 2025 to $15.7 billion by 2030, according to new projections from MarketsandMarkets, representing a compound annual growth rate (CAGR) of 11.7%. This sustained growth is attributed to increased global de
- CollPlant Appoints Bowman Bagley to Lead North American Commercial Operationshttps://modernaesthetics.com/news/collplant-appoints-bowman-bagley-to-lead-north-american-commercial-operations/2475724/CollPlant Biotechnologies has appointed Bowman Bagley as Vice President, Commercial North America, a newly established role aimed at expanding the company’s commercial presence and operations in the region. Bagley will oversee sales, marketing, lo
- The Aesthetic Society Unveils Redesigned Academy for On-Demand Learninghttps://modernaesthetics.com/news/the-aesthetic-society-unveils-redesigned-academy-for-on-demand-learning/2475683/The Aesthetic Society announced the launch of a redesigned interface for The Aesthetic Society Academy, its educational hub for plastic surgeons, aesthetic professionals, residents, and fellows. Available exclusively to Aesthetic Society and Allie
- Study: CINDR of Masseter Muscle Optimal Injection Site for Botoxhttps://modernaesthetics.com/news/study-cindr-of-masseter-muscle-optimal-injection-site-for-botox/2475664/Research published in the Annals of Anatomy journal indicates the center of the intramuscular nerve dense region (CINDR) of the masseter muscle as the optimal botulinum neurotoxin A (BoNT-A) injection site. The researchers used 60 rabbits to assess BoNT-A injection efficacy at the CINDR.<
- LevEllis Launches Regenerative Serum Featuring Skin-Specific Secretome Technologyhttps://modernaesthetics.com/news/levellis-launches-regenerative-serum-featuring-skin-specific-secretome-technology/2475660/LevEllis, Inc. announced the launch of PROVOQUE™, a physician-dispensed regenerative skincare serum formulated with a proprietary skin-specific secretome. Developed by surgeon and molecular biologist Laura Ellis, MD, the product represents a new approach in medical-grade skincare by delivering a
- FDA Reviews sPMA Application for Hyaluronic Acid Injectable to Improve Neck Appearancehttps://modernaesthetics.com/news/fda-reviews-spma-application-for-hyaluronic-acid-injectable-to-improve-neck-appearance/2475595/The U.S. Food and Drug Administration (FDA) has accepted for review a supplemental premarket approval (sPMA) application for SKINVIVE by JUVÉDERM® (Allergan Aesthetics, an AbbVie company), expanding its potential use to include treatment of horizontal neck lines in
- Study Highlights Role of Patient-Reported Outcomes in Botulinum Toxin Developmenthttps://modernaesthetics.com/news/study-highlights-role-of-patient-reported-outcomes-in-botulinum-toxin-development/2475414/A patient-centric clinical approach, driven by the evolution of patient-reported outcomes (PROs), has been central to the development of onabotulinumtoxinA for aesthetic indications, according to new research in the Journal of Cosmetic Dermatology. Researchers concluded there is i